Patents by Inventor David Lyon Garmaise

David Lyon Garmaise has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4001265
    Abstract: A specific anilino derivative of chelocardin having high antibiotic activity is described. This new derivative shows unusually low toxicity and consequently a very high therapeutic index as chemotherapeutic agent against gram-negative organisms.
    Type: Grant
    Filed: March 3, 1975
    Date of Patent: January 4, 1977
    Assignee: Abbott Laboratories
    Inventors: Daniel Tim-Wo Chu, David Lyon Garmaise
  • Patent number: 3988446
    Abstract: Triglycerides carrying the anti-inflammatory drug moiety in the 2-position and hydrocarbon acyl moieties in the 1- and 3-position exhibit excellent anti-inflammatory properties without causing the side effects often associated with the anti-inflammatory drug itself.
    Type: Grant
    Filed: November 7, 1974
    Date of Patent: October 26, 1976
    Assignee: Abbott Laboratories
    Inventors: Gerard Yvon Paris, David Lyon Garmaise
  • Patent number: 3971849
    Abstract: Esters of 1,N.sup.6 -etheno-5'-adenosine carboxylic acid represented by the formula ##SPC1##Wherein R.sub.1 is loweralkyl, loweralkenyl, loweralkynyl or cycloalkyl; and R.sub.2 and R.sub.3 each are hydrogen or acyl, or R.sub.2 and R.sub. 3 taken together form an isopropylidene or benzylidene moiety; and the pharmaceutically acceptable acid addition salts thereof.The compounds wherein R.sub.2 and R.sub.3 are hydrogen are useful in treating cardiovascular disorders and are particularly useful as anti-anginal and anti-hypertensive agents. Compounds wherein R.sub.2 and R.sub.3 are acyl or when taken together form an isopropylidene or benzylidene moiety are intermediates useful in the preparation of the final products. (R.sub.2 and R.sub.3 = hydrogen). The final products are also useful as intermediates for preparing pharmaceutically active compounds, and, more specifically, for preparing the corresponding 1,N.sup.6 -etheno-5'-adenosine carboxamides.
    Type: Grant
    Filed: May 21, 1974
    Date of Patent: July 27, 1976
    Assignee: Abbott Laboratories
    Inventors: Raj Nandan Prasad, David Lyon Garmaise
  • Patent number: 3963774
    Abstract: A number of specific anilino derivatives of chelocardin having high antibiotic activity are described. These new derivatives show unusually low toxicity and consequently a very high therapeutic index as chemotherapeutic agents against gram-negative organisms.
    Type: Grant
    Filed: March 3, 1975
    Date of Patent: June 15, 1976
    Assignee: Abbott Laboratories
    Inventors: Daniel Tim-Wo Chu, David Lyon Garmaise
  • Patent number: 3931401
    Abstract: Amides of 1,N.sup.6 -Etheno-5'-adensine carboxylic acid represented by the formula ##SPC1##Wherein R.sub.1 and R.sub.2 each are hydrogen, loweralkyl, loweralkenyl, loweralkynyl or cycloalkyl, and R.sub.3 and R.sub.4 each are hydrogen, acyl, or R.sub.3 and R.sub.4 taken together form an isopropylidene or benzylidene moiety; and the pharmaceutically acceptable acid addition salts thereof.The compounds wherein R.sub.3 and R.sub.4 are hydrogen are useful in treating cardiovascular disorders and are particularly useful as anti-anginal and anti-hypertensive agents. Compounds wherein R.sub.3 and R.sub.4 are acyl or when taken together form an isopropylidene or benzylidene moiety are intermediates useful in the preparation of the final products. (R.sub.3 and R.sub.4 = hydrogen).
    Type: Grant
    Filed: May 21, 1974
    Date of Patent: January 6, 1976
    Assignee: Abbott Laboratories
    Inventors: Raj Nandan Prasad, David Lyon Garmaise